AI assistant
Sending…
PDS Biotechnology Corp — Director's Dealing 2017
Aug 24, 2017
34613_dirs_2017-08-24_2d24d298-669e-4355-9332-910959a49883.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edge Therapeutics, Inc. (EDGE)
CIK: 0001472091
Period of Report: 2017-08-23
Reporting Person: MARCHIO ALBERT N II (Chief Accounting & Adm Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-23 | Common Stock | S | 1000 | $10.39 | Disposed | 5861 | Direct |
More from PDS Biotechnology Corp
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3